Hungarian breakthrough in Covid-19 treatment: Research findings revealed
Exciting News: Oncology Drug May Be Promising Treatment for COVID-19
Recent research conducted by the HUN-REN Research Centre for Natural Sciences has sparked hope that a drug commonly used in oncology could potentially be repurposed to treat COVID-19. The statement released by the network on Monday highlighted the findings of the research coordinated by Professor Péter Bay of Debrecen University, focusing on the drug Rucaparib.
Rucaparib is known for its ability to block PARP enzymes and according to the research, it may prove effective in both the initial phase of the infection as well as in combating inflammatory complications of the disease in later stages. Senior researcher David Bajusz was quoted in the statement saying, “We have managed to open the way for a unique therapy that can be applied both in the viral and inflammatory phases of the infection, and which also offers an opportunity to prevent further complications in the viral phase.”
The results of this groundbreaking Hungarian research have been recently published in the prestigious British Journal of Pharmacology, shedding light on the potential of Rucaparib as a treatment option for COVID-19.
In addition to this exciting development, other recent news from Hungary includes the discovery of an over 1,000-year-old authentic image of Saint Stephen, the country’s founder, on an unexpected relic, as well as a Hungarian astronomer uncovering previously unknown near-Earth asteroids. Stay tuned for more updates on these fascinating discoveries.
